EC approves Pixuvri for lymphoma

The European Commission granted conditional approval to an MAA from Cell Therapeutics Inc. (NASDAQ:CTIC; Milan:CTIC) for Pixuvri pixantrone to treat patients with multiply relapsed or refractory aggre...